Physician profile
Lorraine Boakye
NPI 1205286416
$20,138.58
in general payments reported to CMS, 2019-2025
13 companies · $1,229 in 2025
The $1,229 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55.56 · 2020: $12.67 · 2021: $1,483 · 2022: $16K · 2023: $796 · 2024: $602 · 2025: $1,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,625.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $15,119.25 | 2021-2025 | |
| Smith+Nephew, INC. | $1,256.13 | 2020-2025 | Panta 2, Stravix Pl, Grafix Pl |
| Stryker Corporation | $1,228.46 | 2022-2025 | Biofoam, Ortholoc 3di, Ortholoc 3di Crosscheck |
| Kairos Surgical INC | $1,213.23 | 2021 | |
| Paragon 28, INC. | $466.59 | 2022-2025 | Ankle Fracture, Trauma, Portfolio |
| Novastep INC. | $324.87 | 2022-2025 | Nexis |
| Liberty Surgical INC. | $177.02 | 2022 | |
| Depuy Synthes Sales INC. | $130.20 | 2025 | Va-Lcp |
| Trilliant Surgical LLC. | $109.35 | 2023 | Minimally Invasive Bunion Plate, Left |
| Terumo Bct, INC. | $55.56 | 2019 | |
| Paladin Technology Solutions | $34.06 | 2023-2024 | |
| Integra Lifesciences Corporation | $23.86 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorraine Boakye listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.